AB, N., ND, J., D, M., MM, L., RC, H., M, D., . . . T, B. (2026). High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Diabetes: A Secondary Analysis of the DANFLU-2 Randomized Clinical Trial. JAMA internal medicine, 186(3), 311. https://doi.org/10.1001/jamainternmed.2025.7286
Chicago Style (17th ed.) CitationAB, Nielsen, et al. "High-Dose Vs Standard-Dose Influenza Vaccine in Older Adults With Diabetes: A Secondary Analysis of the DANFLU-2 Randomized Clinical Trial." JAMA Internal Medicine 186, no. 3 (2026): 311. https://doi.org/10.1001/jamainternmed.2025.7286.
MLA (9th ed.) CitationAB, Nielsen, et al. "High-Dose Vs Standard-Dose Influenza Vaccine in Older Adults With Diabetes: A Secondary Analysis of the DANFLU-2 Randomized Clinical Trial." JAMA Internal Medicine, vol. 186, no. 3, 2026, p. 311, https://doi.org/10.1001/jamainternmed.2025.7286.